Dickhoff C, Leguit R J, Slors J F M, Vervenne W L, Bemelman W A
Departments of Surgery, Academical Medical Center, University Hospital, Amsterdam, The Netherlands.
Case Rep Gastroenterol. 2008 Mar 11;2(1):54-69. doi: 10.1159/000119317.
Giant gastrointestinal stromal tumors (GISTs) of the rectum are rare and often difficult to remove surgically. At the time metastases are found, GISTs are considered to be incurable and until recently no adequate therapy was of any value for these patients. Recently, imatinib was introduced: a signal transducing inhibitor acting specifically on the KIT-tyrosine kinase, which can be used to downsize giant GIST (neo-adjuvant) before surgery or induce stable disease in case of metastases with few minor side-effects. Two patients with giant rectal GIST are presented, one of which was treated before the imatinib era, the other when imatinib was available.
直肠巨大胃肠道间质瘤(GISTs)罕见,手术切除往往困难。当发现转移时,GISTs被认为无法治愈,直到最近,对于这些患者,没有任何充分的治疗方法有价值。最近,伊马替尼被引入:一种特异性作用于KIT酪氨酸激酶的信号转导抑制剂,可用于在手术前缩小巨大GIST(新辅助治疗),或在发生转移时诱导疾病稳定,且副作用较小。本文介绍了两名直肠巨大GIST患者,其中一名在伊马替尼时代之前接受治疗,另一名在有伊马替尼可用时接受治疗。